FDA blocks Indian generic drug imports (KABC-TV Los Angeles)
The FDA blocks imports from India's generic drug giant, citing poor quality in two of its factories.

Ranbaxy disappointed with FDA action (The Times of India)
Wednesday's action by the FDA is the second instance in less than three years of it issuing a warning to Ranbaxy.

Former New York Mayor To Review Compliance Issues-Ranbaxy (Nasdaq)
(RTTNews) - Thursday, Ranbaxy Laboratories announced that they have retained the services of former New York City Mayor Rudy Giuliani and Giuliani partners to provide advice and review compliance issues related to United States Food and Drug Administration letters and import advisory.